CTO & co-founder, Cergentis, NL

BIO

Erik Splinter has, both at the Erasmus MC and the Hubrecht Institute, worked extensively on the development and optimization of technologies for the analysis of 3D structures of human genomes. He has co-authored in peer-reviewed publications in a.o. Genes & Development, Molecular Cell, and Nature Genetics. As Chief Technology Officer at Cergentis he is heading the wet-lab and responsible for the further development of TLA technology and its applications. 

Speaker at
25-26 January 2018, Bruges, Belgium